FTC sues leading Texas anesthesia firm backed by private equity over alleged monopoly scheme

The FTC has accused U.S. Anesthesia Partners and its private equity backer of engaging in a roll-up strategy to monopolize the Texas market.
The FTC alleges that U.S. Anesthesia Partners used its market dominance to raise prices and increase profits at the expense of patients.
Private equity investments in healthcare, including acquiring doctors' practices, have raised concerns about anti-competitive behavior.
U.S. Anesthesia Partners denies the allegations and says it provides high-quality, cost-effective care.
The FTC lawsuit aims to break up the alleged monopoly power and stop anti-competitive conduct.